Modi naturals Limited has filed its mandatory quarterly compliance certificate with stock exchanges, confirming adherence to SEBI regulations regarding dematerialization of securities for the quarter ended March 31, 2026.

Regulatory Filing Details

The company submitted the Certificate under Regulation 74(5) of SEBI (Depositories and Participants) Regulations, 2018 to both major stock exchanges on April 04, 2026. The filing was signed by Rajan Kumar Singh, Company Secretary & Compliance Officer.

RTA Confirmation Certificate

Skyline Financial Services Private Limited, serving as the company's Registrar and Transfer Agent, issued the confirmation certificate dated April 01, 2026. The RTA certified compliance with regulatory requirements for handling physical share certificates during the quarter.

Key Confirmations

The RTA certificate confirms two critical compliance aspects:

• Securities comprised in the certificates have been listed on the stock exchange where earlier issued securities are listed
• Physical certificates were properly mutilated and cancelled after due verification, with the depository name substituted in records as registered owner within the mandated 15-day period

Stock Exchange Communication

The filing was simultaneously submitted to both exchanges where Modi Naturals securities are traded. BSE received the communication referencing scrip code 519003, while NSE was notified using the company's trading symbol MODINATUR.

This quarterly filing represents standard regulatory compliance, ensuring transparency in the dematerialization process and maintaining accurate records of share ownership transfers from physical to electronic form.

Modi Naturals has officially announced the commencement of commercial operations at its expanded ethanol plant through its wholly owned subsidiary Modi Biotech Private Limited. The company has significantly enhanced its ethanol production capabilities at the grain-based facility located in Chhattisgarh.

Capacity Enhancement Details

The expansion represents a substantial increase in production capacity, with the plant's installed capacity enhanced from 130 KLPD to 282 KLPD. This enhancement more than doubles the previous production capabilities, marking a significant milestone in the company's ethanol manufacturing operations.

Regulatory Disclosure

The announcement was made through a formal disclosure under Regulation 30 of SEBI (LODR) Regulations, 2015. Modi Naturals informed stock exchanges BSE and NSE about the commencement of commercial operations at the expanded grain-based ethanol plant operated by Modi Biotech Private Limited, its wholly owned subsidiary.

Strategic Alignment

The development aligns with Modi Naturals' strategic focus on strengthening its presence in the ethanol segment. The expansion also supports the Government of India's Ethanol Blended Petrol (EBP) Programme, positioning the company to contribute to national biofuel objectives.

Operational Impact

According to the company's disclosure, the commencement of commercial operations at the enhanced capacity is expected to improve operational efficiencies and increase production volumes. The expanded facility in Chhattisgarh now serves as a key production hub for Modi Biotech's ethanol manufacturing operations, with the enhanced capacity positioning the company to contribute positively to future growth.